Prediction of symptom-onset in aortic stenosis: a comparison of pressure drop/flow slope and haemodynamic measures at rest.
To compare the pressure drop/flow slope with peak and mean pressure drop, effective orifice area and aortic valve resistance for the prediction of symptom-onset we performed resting and dobutamine stress echocardiography in 49 asymptomatic patients with aortic stenosis (peak aortic velocity>2.5 m/s). The end-point was progression to symptoms requiring surgery and patients were followed for a mean 21.2 (5.2) months. A total of 23 (47%) patients progressed to symptoms requiring aortic valve replacement and 26 remained asymptomatic. There was no significant difference in age, gender, fractional shortening or the presence or absence of coronary artery disease between these groups. There were differences in peak aortic velocity (P<0.0001), peak and mean pressure drop (P<0.0001), effective orifice area (P=0.03), aortic valve resistance (P=0.001) and pressure drop/flow slope (P<0.0001). On Cox regression analysis, the pressure drop/flow slope (P<0.0001), peak aortic velocity (P=0.005) and peak pressure gradient (P=0.02) were independent predictors. Mean event-free survival at 2 years for peak velocity >4.0 m/s was 17% and for pressure drop/flow slope >0.10 mmHg/ms(-1) was 20%. Of 13 patients reporting symptoms during dobutamine stress, 10 (77%) developed spontaneous symptoms during follow-up compared with 13 of 36 (36%) with no symptoms (P=0.11). The pressure drop/flow slope is a better independent predictor of symptom onset than resistance, mean pressure difference and effective orifice area, but is similar to peak velocity.
Takeda
S
S
Valve Study Group, Guy's and St Thomas' Hospitals, London, UK.
Rimington
H
H
Chambers
J
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001021:Aortic Valve / Q000503:physiopathology; D001024:Aortic Valve Stenosis / Q000503:physiopathology*; D001783:Blood Flow Velocity / Q000502:physiology; D001794:Blood Pressure / Q000502:physiology; D025401:Echocardiography, Stress; D023381:Endpoint Determination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D012044:Regression Analysis; D012146:Rest / Q000502:physiology; D014655:Vascular Resistance / Q000502:physiology